Preservation of Fertility and the Impact of Subsequent Pregnancy in Patients With Premenopausal Breast Cancer

Seminars in Oncology

Volumn 33, Issue 6, 2006, Pages 664-671

  Park, Meyeon ^a   Davidson, Rebecca ^a   Fox, Kevin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ALKYLATING AGENT; ANTHRACYCLINE; ANTIBIOTIC AGENT; ANTIESTROGEN; ANTIMETABOLITE; AROMATASE INHIBITOR; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GOSERELIN; LETROZOLE; LEUPRORELIN; METHOTREXATE; PACLITAXEL; PLATINUM DERIVATIVE; TAMOXIFEN; TAXANE DERIVATIVE;

AMENORRHEA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CRYOPRESERVATION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG MECHANISM; EARLY MENOPAUSE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LOW DRUG DOSE; MASTECTOMY; MONOTHERAPY; NONHUMAN; OVARIECTOMY; OVARY INSUFFICIENCY; PARTIAL MASTECTOMY; POSTMENOPAUSE; PREGNANCY; PREMATURE OVARIAN FAILURE; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; FERTILITY; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; NEOPLASMS, HORMONE-DEPENDENT; OVULATION INDUCTION; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PREMENOPAUSE; SURVIVORS;

EID: 35348924040     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.08.015     Document Type: Article

References (90)

1. Hankey B.F., Miller B., Curtis R., et al. Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 16 (1994) 7-14
2. Higgins S., and Haffty B.G. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer 73 (1994) 2175-2180
3. Bines J., Oleske D.M., and Cobleigh M.A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14 (1996) 1718-1729
4. Goodwin P.J., Ennis M., Pritchard K.I., et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 17 (1999) 2365-2370
5. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin 53 (2003) 5
6. Partridge A.H., and Winer E.P. Fertility after breast cancer: questions abound. J Clin Oncol 23 (2005) 4259-4261
7. Hortobagyi G.N. Progress is systemic chemotherapy of primary breast cancer: An overview. J Natl Cancer Inst Monogr 30 (2001) 72-70
8. Poniatowski B.C., Grimm P., and Cohen G. Chemotherapy-induced menopause: A literature review. Cancer Invest 19 (2001) 641-648
9. Shapiro C., and Henderson C. Adjuvant therapy of breast cancer. In: Shapiro C., and Henderon I. (Eds). Hematology/Oncology Clinics of North America New Directions in Breast Cancer Research and Therapeutics (1994), Saunders, Philadelphia, PA 213-230
10. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 351 (1998) 1451-1467
11. Jonat W., Kaufmann M., Wauerbrei W., et al. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex early breast cancer research association study. J Clin Oncol 20 (2002) 4628-4635
12. Meirow D., and Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Human Reprod Update 7 (2001) 535-543
13. Ataya K., and Mognissi K. Chemotherapy-induced ovarian failure: Mechanisms and prevention. Steroids 54 (1989) 607-626
14. Meyn R., and Murray D. Cell cycle effects of alkylating agents. In: Dethlefsen L. (Ed). Cell Cycle Effects of Drugs. (ed 1) (1986), Pergamon, New York, NY 179
15. Pydyn E., and Ataya K. Effect of cyclophosphamide on mouse oocytes in vitro fertilization and cleavage recovery. Reprod Toxicol 5 (1991) 73-78
16. Sonmezer M., and Oktay K. Fertility preservation in female patients. Human Reprod Update 10 (2004) 251-266
17. Fisher B., and Cheung A.Y. Delayed effect of radiation therapy with or without chemotherapy on ovarian function in women with Hodgkin's disease. Acta Radiol Oncol 23 (1984) 43-48
18. Sanders J.E., Hawley J., Levy W., et al. Pregnancies following high dose cyclophosphamide with or without high dose busulfan or total body irradiation and bone marrow transplant. Blood 87 (1996) 3045-3052
19. Moore H.C. Following treatment for breast cancer. The incidence of treatment-related amenorrhea is related to patient age and to the treatment regimen. Curr Oncol Rep 2 (2000) 587-593
20. Thewes B., Meiser B., Duric V., et al. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?. Lancet Oncol 6 (2005) 581-588
21. International Breast Cancer Study Group. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trail. J Natl Cancer Inst 95 (2003) 1833-1846
22. Smith I.E., and Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med 348 (2003) 2431-2442
23. Dellapasqua S., Colleoni M., Gelber R.D., et al. Adjuvant endocrine therapy for premenopausal women with early breast cancer. J Clin Oncol 23 (2005) 1736-1750
24. Meirow D., Lewis H., Nugent D., et al. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: Clinical importance and proposed accurate investigative tool. Hum Reprod 14 (1999) 1902-1907
25. Lower E.E., Blau R., Gazder P., et al. The risk of premature menopause induced by chemotherapy for early breast cancer. J Womens Health Gend Based Med 8 (1999) 939-954
26. Reyno L.M., Levine M.N., Skingley P., et al. Chemotherapy induced amenorrhea in a randomized trial of adjuvant chemotherapy duration in breast cancer. Eur J Cancer 29A (1993) 21-23
27. Byrne J., Fears T.R., Gail M.H., et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166 (1992) 788-793
28. Wallace W.H., Shalet S.M., Tetlow L.J., et al. Ovarian function following the treatment of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 21 (1993) 333-339
29. Chiarelli A.M., Marrett L.D., and Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. AM J. Epidemiol 150 (1999) 245-254
30. Sutton R., Buzdar A.J., and Hortobagyi G.N. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 65 (1990) 847-850
31. Burstein H.J., and Winer E.P. Reproductive issues. In: Harris J.R. (Ed). Diseases of the Breast. (ed 2) (2000), Lippincott Williams & Wilkins, Philadelphia, PA
32. Kramer R., Tham Y., Sexton K., et al. Chemotherapy-induced amenorrhea is increased in patients treated with adjuvant doxorubicin and cyclophosphamide (AC) followed by a taxane (T). Proc Am Soc Clin Oncol 23 (2005) 41s (abstr)
33. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 169 (2000) 123-131
34. Shapiro C.L., Manola J., and Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 19 (2001) 3306-3311
35. Lobo R.A. Potential Options for preservation of fertility in women. N Engl J Med 353 (2005) 64-73
36. Rebar R.W. Premature ovarian failure. In: Lobo R.A., Kelsey J., and Marcus R. (Eds). Menopause: Biology and Pathobiology (2000), Academic Press, San Diego, CA 135-146
37. Letur H., Martin-Pont B., and Fenichel P. Spontaneous pregnancies and premature menopause. Gynecol Obstet Fertil 32 (2004) 748-755
38. Larsen E.C., Muller J., Rechnitzer C., et al. Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l. Hum Reprod 18 (2003) 417-422
39. Mackie E.J., Radford M., and Shalet S.M. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 27 (1996) 74-78
40. Schilsky R.L., Sherins R.J., Hubbard S.M., et al. Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 71 (1981) 552-556
41. Clark S.T., Redford J.A., Crowther D., et al. Gonadal function following chemotherapy for Hodgkin's disease: A comparative study of MVP and a seven-drug hybrid regimen. J Clin Oncol 13 (1995) 134-139
42. Oktay K., Buyuk E., Davis O., et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Human Reprod 18 (2003) 90-95
43. Oktay K., and Karlikaya M. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 342 (2000) 1919
44. Oktay K., Economos K., Kan M., et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA 236 (2001) 1490-1493
45. Oktay K., and Buyuk E. The potential of ovarian tissue transplant to preserve fertility. Expert Opin Biol Ther 2 (2002) 361-370
46. Morita Y., Perez G.I., Paris F., et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6 (2000) 1109-1114
47. 2002 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Atlanta, GA, Centers for Disease Control and Prevention, December 2004. http://www.cdc.gov/reproductivehealth/ART02/PDF/ART2002.pdf (accessed June 13, 2005)
48. Oktay K., Buyuk E., Libertella N., et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23 (2005) 1-7
49. Omland A.K., Fedorcsak P., Storeng R., et al. Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility. Hum Reprod 16 (2001) 2587-2592
50. Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 23 (2005) 3858-3859
51. Crosignani P.G., Bianchedi D., Riccaboni A., et al. Management of anovulatory infertility. Hum Reprod 14 suppl 1 (1999) 108-119
52. Shushan A., Peretz T., and Mor-Yosef S. Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer. Int J Gynaecol Obstet 52 (1996) 249-253
53. Goss P.E., Ingle J.N., Martino S., et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349 (2003) 1793-1802
54. Oktay K., Kan M.T., and Rosenwaks Z. Recent progress in oocytes and ovarian tissue cryopreservation and transplantation. Curr Opin Obstet Gynecol 13 (2001) 263-268
55. Fabbri R., Porcu E., Marsella T., et al. Human oocyte cryopreservation: New perspectives regarding oocyte survival. Hum Reprod 16 (2001) 411-416
56. The Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue and oocytes cryopreservation. Fertil Steril 82 (2004) 993-998
57. Oktay K., Aydin B.A., and Karlikaya G. A technique for laparoscopic transplantation of frozen-banked ovarian tissue. Fertil Steril 75 (2001) 1212-1216
58. Oktay K., Economos K., Kan M., et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA 286 (2001) 1490-1493
59. Oktay K., Buyuk E., Veeck L., et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363 (2004) 837-840
60. Gosden R.G., Baird D.T., Wade J.C., et al. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Reprod 9 (1994) 597-603
61. Sztein J., Sweet H., Farley J., et al. Cryopreservation and orthotopic transplantation of mouse ovaries: New approach in gamete banking. Biol Reprod 58 (1998) 1071-1074
62. Liu J., Van der Elst J., Van den Broecke R., et al. Live offspring by in vitro fertilization of oocytes from cryopreserved primordial mouse follicles after sequential in vivo transplantation and in vitro maturation. Biol Reprod 64 (2001) 171-178
63. Rivkees S.A., and Crawford J.D. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 259 (1988) 2123-2125
64. Meirow D., Assad G., Dor J., et al. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Human Reprod 19 (2004) 1294-1299
65. Couzinet B., Lahlou N., Thomas G., et al. Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and alpha-subunit in postmenopausal women. Clin Endocrinol 34 (1991) 477-483
66. Matikainen T., Ding Y.Q., Vergara M., et al. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women. J Clin Endocrinol Metab 75 (1992) 820-825
67. Rabinovici J., Rothman P., Monroe S.E., et al. Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-rleasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: Studies in postmenopausal women. J Clin Endocrinol Metab 75 (1992) 1220-1225
68. Blumenfeld Z., Avivi I., Linn S., et al. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 11 (1996) 1620-1626
69. Fox K., Scialla J., and Moore H. Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer. Proc Am Soc Clin Oncol 22 (2003) 13 (abstr)
70. Recchia F., Saggio G., Amiconi G., et al. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106 (2006) 514-523
71. DelMastro L., Catzeddu T., and Boni L. Temporary ovarian suppression with goserelin for prevention of chemotherapy-induced menopause in young early breast cancer patients: Results of a phase II study. Proc Am Soc Clin Oncol 23 (2005) 44s (abstr)
72. Jeremias E., Bedaiwy M.A., Gurunluoglu R., et al. Heterotopic autotransplantation of the ovary with microvascular anastomosis: A novel surgical technique. Fertil Steril 77 (2002) 1278-1282
73. Wang X., Chen H., Yin H., et al. Fertility after intact ovary transplantation. Nature 415 (2002) 385
74. Bedaiwy M.A., Jeremias E., Gurunluoglu R., et al. Restoration of ovarian function after autotransplantation of intact frozen-thawed sheep ovaries with microvascular anastomosis. Fertil Steril 79 (2003) 594-602
75. Chiu D.T., and Hu G. Evaluation of the hormonal function and histological features of heterotopic isogenic ovarian transplantation in rats. Plast Reconstr Surg 111 (2003) 1646-1652
76. Saphner T., Tormey D.C., and Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14 (1996) 2738-2846
77. Buzdar A.U., Smith T.L., Blumenschien G.R., et al. Breast cancer adjuvant therapy trials of M.D. Anderson Hospital: Results of two studies. In: Jones S.E., and Salmon S.E. (Eds). Adjuvant Therapy of Cancer IV (1984), Grune & Stratton, Orlando, FL 217-225
78. Danforth D.N. How subsequent pregnancy affects outcome in women with a prior breast cancer. Oncology 5 (1991) 23-30
79. Gelber S., Coates A.S., Goldhirsch A., et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19 (2001) 1671-1675
80. Sankila R., Heinavaara S., and Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: healthy mother effect. Am J Obstet Gynecol 170 (1994) 818-823
81. Blakely L.J., Buzdar A.U., Lozada J.A., et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 200 (2004) 465-469
82. Velentgas P., Daling J.R., Malone K.E., et al. Pregnancy after breast carcinoma: Outcomes and influence on mortality. Cancer 85 (1999) 2424-2432
83. Kroman N., Jensen M.B., Melbye M., et al. Should women be advised against pregnancy after breast-cancer treatment?. Lancet 350 (1997) 319-322
84. von Schoultz E., Johansson H., Wilking N., et al. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 13 (1995) 430-434
85. Malamos N.A., Stathopoulos G.P., Keramopoulos A., et al. Pregnancy and offspring after the appearance of breast cancer. Oncology 53 (1996) 471-475
86. Ariel I.M., and Kempner R. The prognosis of patients who become pregnant after mastectomy for breast cancer. Int Surg 74 (1989) 185-187
87. Petrek J.A., and Theriault R.L. Pregnancy-associated breast cancer and subsequent pregnancy in breast cancer survivors. In: Harris J.R., Lippman M.E., Morrow M., et al. (Eds). Diseases of the Breast (2004), Lippincott, Philadelphia, PA 1035-1046
88. Blatt J., Mulvihill J.J., Zeigler J.L., et al. Pregnancy outcome following cancer chemotherapy. Am J Med 69 (1980) 828-832
89. Mulvihill J.J., McKeen E.A., Rosner F., et al. Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer 60 (1987) 1143-1150
90. Johnson P., Gwyn K., Gordon N., et al. The treatment of pregnant women with breast cancer and the outcomes of children exposed to chemotherapy in utero. Proc Am Soc Clin Oncol 23 (2005) 13s (abstr)